companydata.dkcompanydata.dk

STELLARIS PHARMACEUTICALS ApS: Financial statements 2021

CVR: 34708215

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

STELLARIS PHARMACEUTICALS ApS (CVR 34708215) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -101,607 and a net result of DKK -538,906 compared with DKK -78,835 the year before. Equity in the 2021 report amounted to DKK -894,575. The company had 1 employee in the financial year.

Gross Profit
DKK -101,607
Profit/Loss
DKK -538,906
Equity
DKK -894,575
Total Assets
DKK 244,751
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--102 t.-539 t.-895 t.1
2020--101 t.-79 t.-356 t.-
2019--71 t.-58 t.-277 t.-
2018--70 t.-113 t.-219 t.0
2017--45 t.-78 t.-107 t.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like STELLARIS PHARMACEUTICALS ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

STELLARIS PHARMACEUTICALS ApS: The 2020 annual report is outApr 12, 2021

STELLARIS PHARMACEUTICALS ApS has published its annual report for 2020. Gross profit came to DKK -100,936, and the net result was DKK -78,835.

About STELLARIS PHARMACEUTICALS ApS

STELLARIS PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Birgit Ter-Borch Gram Lilienfeldt Schjoldager. The company is owned by Ranoda Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -475,262 and a net result of DKK -594,882 compared with DKK -486,941 the year before. Equity in the 2025 report amounted to DKK -3,565,816.

Source: annual report 2025, Danish Business Authority